 | • レポートコード：MRC2102QY14589 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の全身性硬化症（強皮症）治療薬市場について種類別（ARG-201、ベリムマブ、BL-1110、BOT-191、C-82、その他）、用途別（病院、診療所、ASC、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・全身性硬化症（強皮症）治療薬市場の概要 ・世界の主要地域別全身性硬化症（強皮症）治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の全身性硬化症（強皮症）治療薬市場規模2015-2026：種類別（ARG-201、ベリムマブ、BL-1110、BOT-191、C-82、その他） ・世界の全身性硬化症（強皮症）治療薬市場規模2015-2026：用途別（病院、診療所、ASC、その他） ・全身性硬化症（強皮症）治療薬の米国市場規模2015-2020 ・全身性硬化症（強皮症）治療薬のヨーロッパ市場規模2015-2020 ・全身性硬化症（強皮症）治療薬の中国市場規模2015-2020 ・全身性硬化症（強皮症）治療薬の日本市場規模2015-2020 ・全身性硬化症（強皮症）治療薬の東南アジア市場規模2015-2020 ・全身性硬化症（強皮症）治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・全身性硬化症（強皮症）治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・全身性硬化症（強皮症）治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Systemic Sclerosis Drug Market
The global Systemic Sclerosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Systemic Sclerosis Drug Scope and Market Size
The global Systemic Sclerosis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Sclerosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Systemic Sclerosis Drug market is segmented into
ARG-201
Belimumab
BL-1110
BOT-191
C-82
Others
Segment by Application, the Systemic Sclerosis Drug market is segmented into
Hospital
Clinic
ASCs
Others
The Systemic Sclerosis Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Systemic Sclerosis Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Systemic Sclerosis Drug Market Share Analysis
Systemic Sclerosis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Systemic Sclerosis Drug business, the date to enter into the Systemic Sclerosis Drug market, Systemic Sclerosis Drug product introduction, recent developments, etc.
The major vendors covered:
Allergan Plc
Angion Biomedica Corp.
arGentis Pharmaceuticals, LLC
Bayer AG
BioLineRx, Ltd.
BiOrion Technologies B.V.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Corbus pharmaceuticals, Inc.
CSL Limited
Daval International Limited
Digna Biotech, S.L.
F. Hoffmann-La Roche Ltd.
Fibrocell Science, Inc.
GenKyoTex S.A.
GlaxoSmithKline Plc
1 Systemic Sclerosis Drug Market Overview
1.1 Systemic Sclerosis Drug Product Scope
1.2 Systemic Sclerosis Drug Segment by Type
1.2.1 Global Systemic Sclerosis Drug Sales by Type (2020-2026)
1.2.2 ARG-201
1.2.3 Belimumab
1.2.4 BL-1110
1.2.5 BOT-191
1.2.6 C-82
1.2.7 Others
1.3 Systemic Sclerosis Drug Segment by Application
1.3.1 Global Systemic Sclerosis Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ASCs
1.3.5 Others
1.4 Systemic Sclerosis Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Systemic Sclerosis Drug Sales Growth Rate (2015-2026)
1.4.2 Global Systemic Sclerosis Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Systemic Sclerosis Drug Price Trends (2015-2026)
2 Systemic Sclerosis Drug Estimate and Forecast by Region
2.1 Global Systemic Sclerosis Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Systemic Sclerosis Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Systemic Sclerosis Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Systemic Sclerosis Drug Revenue Market Share by Region (2015-2020)
2.3 Global Systemic Sclerosis Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Systemic Sclerosis Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Systemic Sclerosis Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Systemic Sclerosis Drug Estimates and Projections (2015-2026)
2.4.2 Europe Systemic Sclerosis Drug Estimates and Projections (2015-2026)
2.4.3 China Systemic Sclerosis Drug Estimates and Projections (2015-2026)
2.4.4 Japan Systemic Sclerosis Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Systemic Sclerosis Drug Estimates and Projections (2015-2026)
2.4.6 India Systemic Sclerosis Drug Estimates and Projections (2015-2026)
3 Global Systemic Sclerosis Drug Competition Landscape by Players
3.1 Global Top Systemic Sclerosis Drug Players by Sales (2015-2020)
3.2 Global Top Systemic Sclerosis Drug Players by Revenue (2015-2020)
3.3 Global Systemic Sclerosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Sclerosis Drug as of 2019)
3.4 Global Systemic Sclerosis Drug Average Price by Company (2015-2020)
3.5 Manufacturers Systemic Sclerosis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Systemic Sclerosis Drug Players (Opinion Leaders)
4 Global Systemic Sclerosis Drug Market Size by Type
4.1 Global Systemic Sclerosis Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Systemic Sclerosis Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Systemic Sclerosis Drug Price by Type (2015-2020)
4.2 Global Systemic Sclerosis Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Systemic Sclerosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Systemic Sclerosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Systemic Sclerosis Drug Price Forecast by Type (2021-2026)
5 Global Systemic Sclerosis Drug Market Size by Application
5.1 Global Systemic Sclerosis Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Systemic Sclerosis Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Systemic Sclerosis Drug Price by Application (2015-2020)
5.2 Global Systemic Sclerosis Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Systemic Sclerosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Systemic Sclerosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Systemic Sclerosis Drug Price Forecast by Application (2021-2026)
6 United States Systemic Sclerosis Drug Market Facts & Figures
6.1 United States Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
6.2 United States Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
6.3 United States Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
7 Europe Systemic Sclerosis Drug Market Facts & Figures
7.1 Europe Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
7.2 Europe Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
7.3 Europe Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
8 China Systemic Sclerosis Drug Market Facts & Figures
8.1 China Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
8.2 China Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
8.3 China Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
9 Japan Systemic Sclerosis Drug Market Facts & Figures
9.1 Japan Systemic Sclerosis Drug Sales Market Share by Company (3015-3030)
9.2 Japan Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
9.3 Japan Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Systemic Sclerosis Drug Market Facts & Figures
10.1 Southeast Asia Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
11 India Systemic Sclerosis Drug Market Facts & Figures
11.1 India Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
11.2 India Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
11.3 India Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Systemic Sclerosis Drug Business
12.1 Allergan Plc
12.1.1 Allergan Plc Corporation Information
12.1.2 Allergan Plc Business Overview
12.1.3 Allergan Plc Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Plc Systemic Sclerosis Drug Products Offered
12.1.5 Allergan Plc Recent Development
12.2 Angion Biomedica Corp.
12.2.1 Angion Biomedica Corp. Corporation Information
12.2.2 Angion Biomedica Corp. Business Overview
12.2.3 Angion Biomedica Corp. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Angion Biomedica Corp. Systemic Sclerosis Drug Products Offered
12.2.5 Angion Biomedica Corp. Recent Development
12.3 arGentis Pharmaceuticals, LLC
12.3.1 arGentis Pharmaceuticals, LLC Corporation Information
12.3.2 arGentis Pharmaceuticals, LLC Business Overview
12.3.3 arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Products Offered
12.3.5 arGentis Pharmaceuticals, LLC Recent Development
12.4 Bayer AG
12.4.1 Bayer AG Corporation Information
12.4.2 Bayer AG Business Overview
12.4.3 Bayer AG Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer AG Systemic Sclerosis Drug Products Offered
12.4.5 Bayer AG Recent Development
12.5 BioLineRx, Ltd.
12.5.1 BioLineRx, Ltd. Corporation Information
12.5.2 BioLineRx, Ltd. Business Overview
12.5.3 BioLineRx, Ltd. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BioLineRx, Ltd. Systemic Sclerosis Drug Products Offered
12.5.5 BioLineRx, Ltd. Recent Development
12.6 BiOrion Technologies B.V.
12.6.1 BiOrion Technologies B.V. Corporation Information
12.6.2 BiOrion Technologies B.V. Business Overview
12.6.3 BiOrion Technologies B.V. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BiOrion Technologies B.V. Systemic Sclerosis Drug Products Offered
12.6.5 BiOrion Technologies B.V. Recent Development
12.7 Boehringer Ingelheim GmbH
12.7.1 Boehringer Ingelheim GmbH Corporation Information
12.7.2 Boehringer Ingelheim GmbH Business Overview
12.7.3 Boehringer Ingelheim GmbH Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Boehringer Ingelheim GmbH Systemic Sclerosis Drug Products Offered
12.7.5 Boehringer Ingelheim GmbH Recent Development
12.8 Bristol-Myers Squibb Company
12.8.1 Bristol-Myers Squibb Company Corporation Information
12.8.2 Bristol-Myers Squibb Company Business Overview
12.8.3 Bristol-Myers Squibb Company Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bristol-Myers Squibb Company Systemic Sclerosis Drug Products Offered
12.8.5 Bristol-Myers Squibb Company Recent Development
12.9 Corbus pharmaceuticals, Inc.
12.9.1 Corbus pharmaceuticals, Inc. Corporation Information
12.9.2 Corbus pharmaceuticals, Inc. Business Overview
12.9.3 Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Products Offered
12.9.5 Corbus pharmaceuticals, Inc. Recent Development
12.10 CSL Limited
12.10.1 CSL Limited Corporation Information
12.10.2 CSL Limited Business Overview
12.10.3 CSL Limited Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSL Limited Systemic Sclerosis Drug Products Offered
12.10.5 CSL Limited Recent Development
12.11 Daval International Limited
12.11.1 Daval International Limited Corporation Information
12.11.2 Daval International Limited Business Overview
12.11.3 Daval International Limited Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Daval International Limited Systemic Sclerosis Drug Products Offered
12.11.5 Daval International Limited Recent Development
12.12 Digna Biotech, S.L.
12.12.1 Digna Biotech, S.L. Corporation Information
12.12.2 Digna Biotech, S.L. Business Overview
12.12.3 Digna Biotech, S.L. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Digna Biotech, S.L. Systemic Sclerosis Drug Products Offered
12.12.5 Digna Biotech, S.L. Recent Development
12.13 F. Hoffmann-La Roche Ltd.
12.13.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.13.2 F. Hoffmann-La Roche Ltd. Business Overview
12.13.3 F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Products Offered
12.13.5 F. Hoffmann-La Roche Ltd. Recent Development
12.14 Fibrocell Science, Inc.
12.14.1 Fibrocell Science, Inc. Corporation Information
12.14.2 Fibrocell Science, Inc. Business Overview
12.14.3 Fibrocell Science, Inc. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Fibrocell Science, Inc. Systemic Sclerosis Drug Products Offered
12.14.5 Fibrocell Science, Inc. Recent Development
12.15 GenKyoTex S.A.
12.15.1 GenKyoTex S.A. Corporation Information
12.15.2 GenKyoTex S.A. Business Overview
12.15.3 GenKyoTex S.A. Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 GenKyoTex S.A. Systemic Sclerosis Drug Products Offered
12.15.5 GenKyoTex S.A. Recent Development
12.16 GlaxoSmithKline Plc
12.16.1 GlaxoSmithKline Plc Corporation Information
12.16.2 GlaxoSmithKline Plc Business Overview
12.16.3 GlaxoSmithKline Plc Systemic Sclerosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 GlaxoSmithKline Plc Systemic Sclerosis Drug Products Offered
12.16.5 GlaxoSmithKline Plc Recent Development
13 Systemic Sclerosis Drug Manufacturing Cost Analysis
13.1 Systemic Sclerosis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Systemic Sclerosis Drug
13.4 Systemic Sclerosis Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Systemic Sclerosis Drug Distributors List
14.3 Systemic Sclerosis Drug Customers
15 Market Dynamics
15.1 Systemic Sclerosis Drug Market Trends
15.2 Systemic Sclerosis Drug Opportunities and Drivers
15.3 Systemic Sclerosis Drug Market Challenges
15.4 Systemic Sclerosis Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Systemic Sclerosis Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Systemic Sclerosis Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Systemic Sclerosis Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Systemic Sclerosis Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Systemic Sclerosis Drug Sales Market Share by Region (2015-2020)
Table 6. Global Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Systemic Sclerosis Drug Revenue Share by Region (2015-2020)
Table 8. Global Systemic Sclerosis Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Systemic Sclerosis Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Systemic Sclerosis Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Systemic Sclerosis Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Systemic Sclerosis Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Systemic Sclerosis Drug Sales Share by Company (2015-2020)
Table 14. Global Systemic Sclerosis Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Systemic Sclerosis Drug Revenue Share by Company (2015-2020)
Table 16. Global Systemic Sclerosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Sclerosis Drug as of 2019)
Table 17. Global Systemic Sclerosis Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Systemic Sclerosis Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Systemic Sclerosis Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Systemic Sclerosis Drug Players
Table 22. Global Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Systemic Sclerosis Drug Sales Share by Type (2015-2020)
Table 24. Global Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Systemic Sclerosis Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Systemic Sclerosis Drug Sales Share by Type (2021-2026)
Table 27. Global Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Systemic Sclerosis Drug Revenue Share by Type (2021-2026)
Table 29. Global Systemic Sclerosis Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Systemic Sclerosis Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Systemic Sclerosis Drug Sales Share by Application (2015-2020)
Table 32. Global Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Systemic Sclerosis Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Systemic Sclerosis Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Systemic Sclerosis Drug Sales Share by Application (2021-2026)
Table 36. Global Systemic Sclerosis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Systemic Sclerosis Drug Revenue Share by Application (2021-2026)
Table 38. Global Systemic Sclerosis Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Systemic Sclerosis Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
Table 41. United States Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
Table 43. United States Systemic Sclerosis Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Systemic Sclerosis Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Systemic Sclerosis Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
Table 51. China Systemic Sclerosis Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
Table 53. China Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
Table 55. China Systemic Sclerosis Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Systemic Sclerosis Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Systemic Sclerosis Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Systemic Sclerosis Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
Table 69. India Systemic Sclerosis Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Systemic Sclerosis Drug Sales Market Share by Company (2015-2020)
Table 71. India Systemic Sclerosis Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Systemic Sclerosis Drug Sales Market Share by Type (2015-2020)
Table 73. India Systemic Sclerosis Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Systemic Sclerosis Drug Sales Market Share by Application (2015-2020)
Table 75. Allergan Plc Corporation Information
Table 76. Allergan Plc Description and Business Overview
Table 77. Allergan Plc Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Allergan Plc Systemic Sclerosis Drug Product
Table 79. Allergan Plc Recent Development
Table 80. Angion Biomedica Corp. Corporation Information
Table 81. Angion Biomedica Corp. Description and Business Overview
Table 82. Angion Biomedica Corp. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Angion Biomedica Corp. Systemic Sclerosis Drug Product
Table 84. Angion Biomedica Corp. Recent Development
Table 85. arGentis Pharmaceuticals, LLC Corporation Information
Table 86. arGentis Pharmaceuticals, LLC Description and Business Overview
Table 87. arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Product
Table 89. arGentis Pharmaceuticals, LLC Recent Development
Table 90. Bayer AG Corporation Information
Table 91. Bayer AG Description and Business Overview
Table 92. Bayer AG Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Bayer AG Systemic Sclerosis Drug Product
Table 94. Bayer AG Recent Development
Table 95. BioLineRx, Ltd. Corporation Information
Table 96. BioLineRx, Ltd. Description and Business Overview
Table 97. BioLineRx, Ltd. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. BioLineRx, Ltd. Systemic Sclerosis Drug Product
Table 99. BioLineRx, Ltd. Recent Development
Table 100. BiOrion Technologies B.V. Corporation Information
Table 101. BiOrion Technologies B.V. Description and Business Overview
Table 102. BiOrion Technologies B.V. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. BiOrion Technologies B.V. Systemic Sclerosis Drug Product
Table 104. BiOrion Technologies B.V. Recent Development
Table 105. Boehringer Ingelheim GmbH Corporation Information
Table 106. Boehringer Ingelheim GmbH Description and Business Overview
Table 107. Boehringer Ingelheim GmbH Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Boehringer Ingelheim GmbH Systemic Sclerosis Drug Product
Table 109. Boehringer Ingelheim GmbH Recent Development
Table 110. Bristol-Myers Squibb Company Corporation Information
Table 111. Bristol-Myers Squibb Company Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Bristol-Myers Squibb Company Description and Business Overview
Table 113. Bristol-Myers Squibb Company Systemic Sclerosis Drug Product
Table 114. Bristol-Myers Squibb Company Recent Development
Table 115. Corbus pharmaceuticals, Inc. Corporation Information
Table 116. Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Corbus pharmaceuticals, Inc. Description and Business Overview
Table 118. Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Product
Table 119. Corbus pharmaceuticals, Inc. Recent Development
Table 120. CSL Limited Corporation Information
Table 121. CSL Limited Description and Business Overview
Table 122. CSL Limited Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. CSL Limited Systemic Sclerosis Drug Product
Table 124. CSL Limited Recent Development
Table 125. Daval International Limited Corporation Information
Table 126. Daval International Limited Description and Business Overview
Table 127. Daval International Limited Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Daval International Limited Systemic Sclerosis Drug Product
Table 129. Daval International Limited Recent Development
Table 130. Digna Biotech, S.L. Corporation Information
Table 131. Digna Biotech, S.L. Description and Business Overview
Table 132. Digna Biotech, S.L. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Digna Biotech, S.L. Systemic Sclerosis Drug Product
Table 134. Digna Biotech, S.L. Recent Development
Table 135. F. Hoffmann-La Roche Ltd. Corporation Information
Table 136. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 137. F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Product
Table 139. F. Hoffmann-La Roche Ltd. Recent Development
Table 140. Fibrocell Science, Inc. Corporation Information
Table 141. Fibrocell Science, Inc. Description and Business Overview
Table 142. Fibrocell Science, Inc. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Fibrocell Science, Inc. Systemic Sclerosis Drug Product
Table 144. Fibrocell Science, Inc. Recent Development
Table 145. GenKyoTex S.A. Corporation Information
Table 146. GenKyoTex S.A. Description and Business Overview
Table 147. GenKyoTex S.A. Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. GenKyoTex S.A. Systemic Sclerosis Drug Product
Table 149. GenKyoTex S.A. Recent Development
Table 150. GlaxoSmithKline Plc Corporation Information
Table 151. GlaxoSmithKline Plc Description and Business Overview
Table 152. GlaxoSmithKline Plc Systemic Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. GlaxoSmithKline Plc Systemic Sclerosis Drug Product
Table 154. GlaxoSmithKline Plc Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Systemic Sclerosis Drug Distributors List
Table 158. Systemic Sclerosis Drug Customers List
Table 159. Systemic Sclerosis Drug Market Key Trends
Table 160. Systemic Sclerosis Drug Key Opportunities and Drivers
Table 161. Systemic Sclerosis Drug Market Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Systemic Sclerosis Drug Product Picture
Figure 2. Global Systemic Sclerosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Systemic Sclerosis Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. ASCs Examples
Figure 9. Others Examples
Figure 10. Global Systemic Sclerosis Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Systemic Sclerosis Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Systemic Sclerosis Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Systemic Sclerosis Drug Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Systemic Sclerosis Drug Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Systemic Sclerosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Systemic Sclerosis Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Systemic Sclerosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Systemic Sclerosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Systemic Sclerosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Systemic Sclerosis Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Systemic Sclerosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Systemic Sclerosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Systemic Sclerosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Systemic Sclerosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Systemic Sclerosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Systemic Sclerosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Systemic Sclerosis Drug Players Market Share by Revenue in Systemic Sclerosis Drug 2015 & 2019
Figure 28. Systemic Sclerosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Systemic Sclerosis Drug Revenue Share by Type (2015-2020)
Figure 30. Global Systemic Sclerosis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Systemic Sclerosis Drug Revenue Share by Application (2015-2020)
Figure 32. Global Systemic Sclerosis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Systemic Sclerosis Drug Sales Market Share by Type in 2019
Figure 34. United States Systemic Sclerosis Drug Sales Market Share by Type in 2019
Figure 35. Europe Systemic Sclerosis Drug Sales Market Share by Company in 2019
Figure 36. Europe Systemic Sclerosis Drug Sales Market Share by Type in 2019
Figure 37. Europe Systemic Sclerosis Drug Sales Market Share by Application in 2019
Figure 38. China Systemic Sclerosis Drug Sales Market Share by Company in 2019
Figure 39. China Systemic Sclerosis Drug Sales Market Share by Type in 2019
Figure 40. China Systemic Sclerosis Drug Sales Market Share by Application in 2019
Figure 41. Japan Systemic Sclerosis Drug Sales Market Share by Company in 2019
Figure 42. Japan Systemic Sclerosis Drug Sales Market Share by Type in 2019
Figure 43. Japan Systemic Sclerosis Drug Sales Market Share by Application in 2019
Figure 44. Southeast Asia Systemic Sclerosis Drug Sales Market Share by Company in 2019
Figure 45. Southeast Asia Systemic Sclerosis Drug Sales Market Share by Type in 2019
Figure 46. Southeast Asia Systemic Sclerosis Drug Sales Market Share by Application in 2019
Figure 47. India Systemic Sclerosis Drug Sales Market Share by Company in 2019
Figure 48. India Systemic Sclerosis Drug Sales Market Share by Type in 2019
Figure 49. India Systemic Sclerosis Drug Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Systemic Sclerosis Drug
Figure 52. Manufacturing Process Analysis of Systemic Sclerosis Drug
Figure 53. Systemic Sclerosis Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
多発性硬化症（MS）治療薬の世界市場レポート2020 Market Analysis and Insights: Global Multiple Sclerosis (MS) Drugs Market The global Multiple Sclerosis (MS) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Multiple Sclerosis (MS) Drugs Scope and Market Size The …- I型高脂血症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Type I Hyperlipoproteinemia Drug Market The global Type I Hyperlipoproteinemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Type I Hyperlipoproteinemia Drug Scope and Market …
- 原発性高シュウ酸尿症薬の世界市場レポート2020 Market Analysis and Insights: Global Primary Hyperoxaluria Drug Market The global Primary Hyperoxaluria Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Primary Hyperoxaluria Drug Scope and Market Size The global Pr…
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drug Market The global Endocrine System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Endocrine System Drug Scope and Market Size The global Endocrine System …
- 消化器系治療薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drug Market The global Digestive System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Digestive System Drug Scope and Market Size The global Digestive System …